Welcome to the World of Izervay
Discover Izervay™ (avacincaptad pegol), a breakthrough prescription eye injection for adults with geographic atrophy (GA), an advanced form of dry age-related macular degeneration (AMD). FDA-approved in August 2023, Izervay slows GA progression by targeting C5, helping preserve vision longer. This pre-landing page invites you to explore how Izervay, backed by Astellas’ commitment to patients, empowers you to protect your eyesight and maintain independence. Take the first step toward clearer tomorrows.
What Makes Izervay Stand Out?
Izervay is a pioneering complement C5 inhibitor that slows GA progression by 18–35% compared to untreated patients, as shown in the GATHER1 and GATHER2 clinical trials. By blocking C5, Izervay protects retinal cells, delaying vision loss and helping patients maintain daily activities like reading or driving. The Izervay My Way™ program offers personalized support, including financial assistance and appointment reminders, ensuring accessible care. With over 210,000 vials distributed by December 2024, Izervay is a trusted choice for retina specialists and patients alike.
Explore Izervay’s Key Features
Izervay is designed to fit seamlessly into your life with a 2 mg (0.1 mL) monthly eye injection administered by a retina specialist, typically taking seconds with minimal discomfort. Clinical benefits are seen as early as 6 months, with sustained vision preservation over 2 years. The Izervay My Way™ program provides copay assistance, insurance navigation, and access to community resources like MacularDegeneration.net. Patients are advised to monitor for side effects like temporary eye pressure or blurred vision, ensuring proactive care. Izervay empowers you to stay engaged with your world.
Get Inspired to Protect Your Vision
Izervay is more than a treatment—it’s a commitment to preserving your vision and quality of life. For the 1.5 million Americans living with GA, Izervay offers hope by slowing disease progression, helping you stay connected with loved ones and daily routines. With a robust support system and proven results, Izervay encourages early action to maximize benefits. This is your moment to take control of your eye health and explore how Izervay can make a difference.
Izervay: A Vision for Hope
This is your opportunity to embrace a treatment that slows the progression of geographic atrophy, offering a brighter future for your vision. Izervay, developed by Astellas, combines innovative science with patient-centered support through the Izervay My Way™ program. Visit Izervay’s official website to learn more about this FDA-approved therapy, find a retina specialist, and access resources to navigate your GA journey. Act early and join the Izervay community today.